Results 191 to 200 of about 91,737 (262)
Prophylactic hyperthermic ıntraperitoneal chemotherapy for radiologic T4 colorectal cancer: impact on locoregional control. [PDF]
Argın V +6 more
europepmc +1 more source
DPSC‐IVs suppressed PI3K/AKT/mTOR signalling pathway by delivering PTEN to tumour cells, which reduced the expression of Bcl‐2 and elevated that of Bax. Meanwhile, DPSC‐IVs activated PINK1/Parkin mediated mitophagy, which further raised ROS levels.
Yu Luo +10 more
wiley +1 more source
High-grade appendiceal mucinous neoplasm: case report. [PDF]
Arrieta Navarro JC +5 more
europepmc +1 more source
Summary Melanomas are among the most frequent neoplasms in grey horses. Deep perirectal melanomas, however, are uncommon and challenging to excise due to their proximity to the peritoneal reflection. This report describes the successful standing removal of a large (16 × 8 × 6 cm) perirectal melanoma firmly adherent to the dorsal rectal wall in a 19 ...
R. Becker, C. Koch, M. de Preux
wiley +1 more source
Revisiting the enigma of a large symptomatic peritoneal loose body: a case report and critical literature review. [PDF]
Dholakia V, Jena SS, Yadav A, Nundy S.
europepmc +1 more source
Clinical and surgical findings in a mare with unilateral ovarian fibroleiomyoma and adhesions
Summary This case report describes the clinical presentation, ultrasonographic findings, surgical management and outcome of a 7‐year‐old Warmblood mare presented for recurrent colic, weight loss and poor performance. Rectal palpation identified a firm mass in the left caudal abdomen, which appeared on ultrasonography as a large, fluid‐filled, cyst‐like
N. Scilimati +8 more
wiley +1 more source
Carbohydrate antigen 72-4 and tumor-associated glycoprotein 72 - tumor marker: Past, present and future. [PDF]
Ng RK, Shelat VG.
europepmc +1 more source
BJU International, Volume 135, Issue 4, Page 700-705, April 2025.
Yubo Wang +10 more
wiley +1 more source
Combining TAG‐72CAR with anti‐MUC16CAR improves the potency of ovarian cancer treatment
Tz‐KBBCAR, a combinatorial CAR targeting MUC16 and TAG‐72, enhances the precision of ovarian cancer immunotherapy. By requiring both tumour antigens for full activation, Tz‐KBBCAR was designed to eliminate MUC16+/TAG‐72+ cancer cells, while sparing MUC16+/TAG‐72‐ healthy cells.
Alicia Villatoro +13 more
wiley +1 more source

